A delayed chemically induced tumorigenesis in Brca2 mutant mice

Oncogene

Volumn 23, Issue 10, 2004, Pages 1896-1901

  Yan, Duen Hwa ^a,c   Wen, Yong ^a,c   Su, Li Kuo ^a,c   Xia, Weiya ^a   Wang, Shao Chun ^a   Zhang, Su ^a   Gan, Lin ^b   Lee, Dung Fang ^a,c   Spohn, Bill ^a   Frey, Jennifer A ^a,c   Hortobagyi, Gabriel N ^d   Hung, Mien Chie ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Brca2; Carcinogenesis; DMBA; Knockout; Mammary tumors

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; BRCA2 PROTEIN; CARCINOGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER MORTALITY; CANCER RISK; CANCER SUSCEPTIBILITY; CELL ASSAY; CHEMICAL CARCINOGENESIS; CIGARETTE SMOKING; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DOSE RESPONSE; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN CELL; IN VITRO STUDY; KNOCKOUT MOUSE; MOUSE; MOUSE MUTANT; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; WILD TYPE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; APOPTOSIS; BRCA2 PROTEIN; CARCINOGENS; FEMALE; GENES, BRCA2; GENOMIC LIBRARY; GERM-LINE MUTATION; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, KNOCKOUT; STEM CELLS;

ANIMALIA;

EID: 11144356465     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207314     Document Type: Article

References (36)

1. Abbott DW, Freeman ML and Holt JT. (1998). J. Natl. Cancer Inst., 90, 978-985.
2. Aldaz CM, Liao QY, LaBate M and Johnston DA. (1996a). Carcinogenesis, 17, 2069-2072.
3. Aldaz CM, Liao QY, Paladugu A, Rehm S and Wang H. (1996b). Mol. Carcinogen., 17, 126-133.
4. Bennett LM, McAllister KA, Blackshear PE, Malphurs J, Goulding G, Collins NK, Ward T, Bunch DO, Eddy EM, Davis BJ and Wiseman RW. (2000). Mol. Carcinogen., 28, 174-183.
5. Boyd J, Sonoda Y, Federici MG, Bogomolniy F, Rhei E, Maresco DL, Saigo PE, Almadrones LA, Barakat RR, Brown CL, Chi DS, Curtin JP, Poynor EA and Hoskins WJ. (2000). JAMA, 283, 2260-2265.
6. Brunet JS, Ghadirian P, Rebbeck TR, Lerman C, Garber JE, Tonin PN, Abrahamson J, Foulkes WD, Daly M, Wagner-Costalas J, Godwin A, Olopade OI, Moslehi R, Liede A, Futreal PA, Weber BL, Lenoir GM, Lynch HT and Narod SA. (1998). J. Natl. Cancer Inst., 90, 761-766.
7. Connor F, Bertwistle D, Mee PJ, Ross GM, Swift S, Grigorieva E, Tybulewicz VL and Ashworth A. (1997). Nat. Genet., 17, 423-430.
8. Ding Y, Wen Y, Spohn B, Wang L, Xia W, Kwong KY, Shao R, Li Z, Hortobagyi GN, Hung MC and Yan DH. (2002). Clin. Cancer Res., 8, 3290-3297.
9. Egawa C, Miyoshi Y, Takamura Y, Taguchi T, Tamaki Y and Noguchi S. (2001). Int. J. Cancer, 95, 255-259.
10. Friedman LS, Thistlethwaite FC, Patel KJ, Yu VP, Lee H, Venkitaraman AR, Abel KJ, Carlton MB, Hunter SM, Colledge WH, Evans MJ and Ponder BA. (1998). Cancer Res., 58, 1338-1343.
11. Gavrieli Y, Sherman Y and Ben-Sasson SA. (1992). J. Cell Biol., 119, 493-501.
12. Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH and Kern SE. (1996). Cancer Res., 56, 5360-5364.
13. Hecht SS. (2002). Environ. Mol. Mutagen., 39, 119-126.
14. Kaplan EL and Meier P. (1958). J. Am. Stat. Assoc., 53, 457-481.
15. Knudson Jr AG. (1971). Proc. Natl. Acad. Sci. USA, 68, 820-823.
16. Levine DA, Federici MG, Reuter VE and Boyd J. (2002). Gynecol. Oncol., 85, 431-434.
17. Ludwig T, Chapman DL, Papaioannou VE and Efstratiadis A. (1997). Genes Dev., 11, 1226-1241.
18. Ludwig T, Fisher P, Murty V and Efstratiadis A. (2001). Oncogene, 20, 3937-3948.
19. Maniatis T, Fritsch EF and Sambrook J. (1982). Molecular Cloning - A Laboratory Manual. Harbor Laboratory: Cold Spring.
20. McAllister KA, Bennett LM, Houle CD, Ward T, Malphurs J, Collins NK, Cachafeiro C, Haseman J, Goulding EH, Bunch D, Eddy EM, Davis BJ and Wiseman RW. (2002). Cancer Res., 62, 990-994.
21. McMahon AP and Bradley A. (1990). Cell, 62, 1073-1085.
22. Morimatsu M, Donoho G and Hasty P. (1998). Cancer Res., 58, 3441-3447.
23. Orelli BJ and Bishop DK. (2001). Breast Cancer Res., 3, 294-298.
24. Patel KJ, Vu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, Colledge WH, Friedman LS, Ponder BA and Venkitaraman AR. (1998). Mol. Cell, 1, 347-357.
25. Pena JC, Rudin CM and Thompson CB. (1998). Cancer Res., 58, 2111-2116.
26. Schwab M, Claas A and Savelyeva L. (2002). Cancer Lett., 175, 1-8.
27. Scully R and Puget N. (2002). Biochimie, 84, 95-102.
28. Sharan SK and Bradley A. (1997). Genomics, 40, 234-241.
29. Su LK, Wang SC, Qi Y, Luo W, Hung MC and Lin SH. (1998). Oncogene, 17, 2377-2381.
30. Suzuki A, de la Pompa JL, Hakem R, Elia A, Yoshida R, Mo R, Nishina H, Chuang T, Wakeham A, Itie A, Koo W, Billia P, Ho A, Fukumoto M, Hui CC and Mak TW. (1997). Genes Dev., 11, 1242-1252.
31. Venkitaraman AR. (2001a). Curr. Opin. Cell Biol., 13, 338-343.
32. Venkitaraman AR. (2001b). J. Cell Sci., 114, 3591-3598.
33. Venkitaraman AR. (2002). Cell, 108, 171-182.
34. Wang SC, Shao R, Pao AY, Zhang S, Hung MC and Su LK. (2002). Cancer Res., 62, 1311-1314.
35. Welcsh PL and King MC. (2001). Hum. Mol. Genet., 10, 705-713.
36. Zheng L, Li S, Boyer TG and Lee WH. (2000). Oncogene, 19, 6159-6175.